All In Biotech

Drug Trial Radar · NCT06481215

A Safety and Pharmacokinetics Study of Ustekinumab Biosimilar GNR-068 and Stelara® in Healthy Volunteers

An Randomized Comparative Parallel-group Trial of the Safety, Pharmacokinetics, and Immunogenicity of the Drug GNR-068 and the Drug Stelara® After Their Single Subcutaneous Administration to Healthy Volunteers at a Dose of 45 mg

Last checked: Nov 19, 2026Latest source record: Jul 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 122 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

122

Actual

Start

Mar 11, 2022

Primary completion

Sep 4, 2022

Study completion Dec 20, 2022

Sponsor

Lead sponsor
AO GENERIUMIndustry
Sponsor type
Industry
First posted
Jul 1, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a randomized open comparative parallel group study of the safety and pharmacokinetics of GNR-068 and Stelara® in healthy volunteers. Participants received a single subcutaneous dose of ustekinumab 45 mg. The follow up period was 84 days.

Conditions

  • Healthy Volunteers

Interventions

  • GNR-068Biological

    The investigational product GNR-068 was administered as a subcutaneous injection at a single dose of 45 mg.

  • Stelara®Biological

    The reference product Stelara® was administered as a subcutaneous injection at a single dose of 45 mg.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetics: Area under the plasma concentration versus time curve (AUC)Time frame: Day 84
  2. Pharmacokinetics: Peak Plasma Concentration (Cmax)Time frame: Day 84

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • State budgetary healthcare institution of the city of Moscow "City Clinic No. 2 of the Moscow Health Department"

    Moscow, Russia

  • Federal State Budgetary Educational Institution of Higher Education "Moscow State Medical and Dental University named after A.I. Evdokimov" of the Ministry of Health of the Russian Federation

    Moscow, Russia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.